Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Sphingosine 1-Phosphate and Voriconazole

supplement:

Sphingosine 1-Phosphate

drug:

Voriconazole

Research Papers that Mention the Interaction

“ VRCZ shows high antifungal activity to Candida spp.”
[Voriconazole-medicalneeds, evidence, potential for the future].
Nihon Ishinkin Gakkai zasshi = Japanese journal of medical mycology  •  2005  |  View Paper
“ Voriconazole was active against all Candida spp.,”
Activity of echinocandins and triazoles against a contemporary (2012) worldwide collection of yeast and moulds collected from invasive infections.
International journal of antimicrobial agents  •  2014  |  View Paper
“ Voriconazole was active against all Candida spp.”
Echinocandin and Triazole Antifungal Susceptibility Profiles for Clinical Opportunistic Yeast and Mold Isolates Collected from 2010 to 2011: Application of New CLSI Clinical Breakpoints and Epidemiological Cutoff Values for Characterization of Geographic and Temporal Trends of Antifungal Resistance
Journal of Clinical Microbiology  •  2013  |  View Paper
“Compared to fluconazole, voriconazole demonstrates enhanced activity against Candida spp. (”
“ Voriconazole has broad-spectrum activity against Candida spp.”
Fixed-Ratio Combination Testing of an Echinocandin, Anidulafungin, and an Azole, Voriconazole, against 1,467 Candida Species Isolates
Antimicrobial Agents and Chemotherapy  •  2010  |  View Paper
“Either fluconazole or voriconazole MIC results may serve as surrogate markers to predict the susceptibility of Candida spp.”
Selection of a Surrogate Agent (Fluconazole or Voriconazole) for Initial Susceptibility Testing of Posaconazole against Candida spp.: Results from a Global Antifungal Surveillance Program
Journal of Clinical Microbiology  •  2007  |  View Paper
“In vitro studies have suggested that VRC has potent activity against Candida spp.”
Triazole Cross-Resistance among Candida spp.: Case Report, Occurrence among Bloodstream Isolates, and Implications for Antifungal Therapy
Journal of Clinical Microbiology  •  2006  |  View Paper
“In conclusion, our data show that the fungicidal effect of voriconazole against Candida spp.”
Potential fungicidal effect of voriconazole against Candida spp.
International journal of antimicrobial agents  •  2005  |  View Paper
“ Voriconazole and posaconazole were very active against Candida spp. (”
In vitro activities of voriconazole, posaconazole, and fluconazole against 4,169 clinical isolates of Candida spp. and Cryptococcus neoformans collected during 2001 and 2002 in the ARTEMIS global antifungal surveillance program.
Diagnostic microbiology and infectious disease  •  2004  |  View Paper
“ Voriconazole and posaconazole were quite active against all Candida spp.”
[In vitro activity of fluconazole, voriconazole and posaconazole against Candida spp].
Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia  •  2003  |  View Paper
“These results demonstrate that voriconazole , in addition to its direct inhibitory activity against fungi, may act against Candida spp.”
The effect of the new triazole, voriconazole (UK-109,496), on the interactions of Candida albicans and Candida krusei with endothelial cells.
Journal of chemotherapy  •  1998  |  View Paper
Show More